Search For "covid 19 antibody"
Rapid rise in COVID-19 cases in Kerala could be due to Omicron, says Keral
Updated : 4 years, 4 months ago IST
Thiruvananthapuram (Kerala) [India], January 19 (ANI): The rising cases of COVID-19 in Kerala could be due to the presence of the Omicron variant of the virus, said Dr GS Vijayakrishnan, the President of Kerala Government Medical Officers Association on Tuesday.
Read More
Blood clots in people with severe COVID-19 may be related to abnormal anti
Updated : 4 years, 10 months ago IST
London [UK], July 28 (ANI): Inflammation and blood clotting seen in very severe cases of Covid-19 may be caused by the antibodies sent to fight the disease activating unnecessary platelet activity in the lungs.
Read More
AstraZeneca's antibody treatment fails to protect against COVID-19
Updated : 4 years, 11 months ago IST
Moscow [Russia], June 15 (ANI/Sputnik): AstraZeneca announced on Tuesday that the clinical trial of its long-acting antibody cocktail has not provided evidence of effectiveness in protecting people exposed to the coronavirus.
Read More
COVID antibody cocktail now offered to patients at Indraprastha Apollo Hos
Updated : 5 years ago IST
New Delhi [India], May 28 (ANI): Roche India's Antibody Cocktail (Casirivimab and Imdevimab) is now available as a therapy to treat patients with mild and moderate COVID-19 infection at the Indraprastha Apollo Hospitals in Delhi, the hospital said in a statement on Friday.
Read More
DST funded start-up's ELISA test to better estimate COVID 19 antibody conc
Updated : 5 years ago IST
New Delhi [India], May 22 (ANI): A Department of Science and Technology (DST) supported technology-- Electrochemical ELISA test -- enables fast and accurate estimation of antibody concentration of COVID-19 in clinical samples, Ministry of Science and Technology said on Saturday.
Read More
Global sales of Celltrion's COVID-19 antibody-drug Regkirona begin
Updated : 5 years ago IST
Seoul [South Korea], May 12 (ANI/Global Economic): Worldwide sales of Regkirona (active ingredient: regdanvimab), a COVID-19 antibody drug developed by South Korean biopharmaceutical company Celltrion Inc, has begun.
Read More
Regeneron antibody cocktail 'helps prevent' symptomatic Covid-19: Drugmake
Updated : 5 years, 1 month ago IST
New York [US], April 13 (ANI): New Phase 3 trial data finds a single shot of Regeneron's Covid-19 antibody cocktail was able to prevent symptomatic Covid-19 among people exposed to the virus, the company said on Monday.
Read More
Regeneron's COVID-19 treatment 'reduces hospitaliations' by 70 pc
Updated : 5 years, 2 months ago IST
New York [US], March 23 (ANI): Regeneron Pharmaceuticals Inc on Tuesday said that its dual antibody treatment for COVID-19 reduced symptomatic illness by four days at any level of dose tried in its clinical trial adding that the treatment also seemed to reduce hospitalizations and death by a
Read More
Research shows Regeneron's COVID-19 antibody cocktail effective against co
Updated : 5 years, 4 months ago IST
New York [US], January 28 (ANI): The tests conducted on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron's cocktail therapy can neutralize both, despite the mutations, researchers reported on Wednesday.
Read More
US launches Phase 3 trial of 2 new antibody treatments for COVID-19
Updated : 5 years, 5 months ago IST
Washington [US], December 18 (ANI): The United States, on Thursday, announced phase 3 clinical trials of two experimental drugs to treat hospitalized COVID-19 patients when combined with existing treatments, said the National Institute for Allergy and Infectious Diseases (NIAID) (local time
Read More
US allows emergency use of Eli Lilly's COVID-19 antibody treatment
Updated : 5 years, 6 months ago IST
Washington DC [US], November 10 (ANI): The US Food and Drug Administration (FDA) has approved an emergency use authorisation (EUA) for American pharmaceutical company Eli Lilly's experimental COVID-19 antibody treatment called 'bamlanivimab' for non-hospitalised patients with mild-to-moderat
Read More
Re-engineering antibodies for COVID-19
Updated : 5 years, 10 months ago IST
Texas [USA], August 3 (ANI): With millions of COVID-19 cases reported across the globe, people are turning to antibody tests to find out whether they have been exposed to the coronavirus that causes the disease.
Read More